Medable Introduces Agentic Accelerator Program to Enhance AI Integration in Clinical Trials
Medable Launches Agentic Accelerator Program to Help Life Sciences Companies Deploy Agentic AI Across Clinical Lifecycle
Image: Businesswire
Medable Inc. has launched the Agentic Accelerator Program aimed at assisting life sciences companies in implementing agentic AI throughout the clinical development lifecycle. This initiative promises to enhance operational efficiency and accelerate the realization of value from AI technologies.
- 01The Agentic Accelerator Program offers onboarding, integration support, governance, and change management for life sciences companies.
- 02Only 22% of life sciences leaders have successfully scaled AI across their enterprises, highlighting the need for effective implementation strategies.
- 03The program features a dedicated team of AI clinical development experts and forward-deployed engineers to ensure rapid deployment of AI solutions.
- 04Medable's Agent Studio allows for the creation and deployment of AI agents across clinical workflows with compliance and governance features.
- 05Medable has been involved in nearly 400 trials across 70 countries, enhancing the speed and access of clinical research.
Advertisement
In-Article Ad
Medable Inc., based in Palo Alto, California, has launched the Agentic Accelerator Program to assist life sciences companies in effectively deploying agentic AI throughout the clinical development lifecycle. This program provides comprehensive support, including onboarding, integration assistance, governance, and change management, enabling organizations to derive value from AI solutions from the outset. Currently, only 22% of life sciences leaders have successfully scaled AI, emphasizing the necessity for strategic partnerships that can facilitate rapid implementation and return on investment (ROI). The program is backed by a dedicated team of experts who help clients navigate standard agentic use cases while also developing tailored workflows. Furthermore, Medable's Agent Studio offers a purpose-built platform for creating AI agents, ensuring compliance and operational transparency across clinical trials. Medable's mission is to accelerate the availability of effective therapies, having supported nearly 400 trials globally, enhancing patient access and research efficiency.
Advertisement
In-Article Ad
The Agentic Accelerator Program is expected to significantly improve the efficiency and effectiveness of clinical trials, potentially leading to faster delivery of therapies.
Advertisement
In-Article Ad
Reader Poll
How do you view the impact of AI in clinical trials?
Connecting to poll...
Read the original article
Visit the source for the complete story.